NAPIGEN, INC.
2Patents
2Active
2Granted
53Portfolio score
Filing activity: Jul 18, 2022 → Jan 19, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11920140B2 | Organelle genome modification using polynucleotide guided endonuclease | Chemistry; Metallurgy | 1 | Active |
| US12173295B2 | Organelle genome modification using polynucleotide guided endonuclease | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.